News

Time to Shutter Low-Volume Transplant Centers?


 

SNOWMASS, COLO. — The number of U.S. heart transplant centers needs to be cut by about two-thirds.

With more than 140 heart transplant programs now in place in the United States, relatively few centers have a reasonable case volume. In fact, the number of high-volume centers is actually declining as centers compete for the extremely limited number of donor organs, according to Dr. Bruce W. Lytle, professor and chair of cardiothoracic surgery at the Cleveland Clinic Foundation.

It's a situation that cries out for national regulation, Dr. Lytle said at a conference sponsored by the American College of Cardiology. “Organ allocation and utilization would probably be a lot more efficient under those circumstances, the surgeon said.

International Society for Heart and Lung Transplantation (ISHLT) data show that 30-day mortality is doubled at cardiac transplant centers performing fewer than 10 procedures per year. Of all U.S. centers, 45% consistently do fewer than 10 procedures annually, and during a recent 8-year period fully 66% of centers failed to reach the 10-case mark in all 8 years (Ann. Thorac. Surg. 2008;86:1250-9).

Survival 5 years post transplant is currently about 80%, with superb quality of life. “Cardiac transplantation is really one of the great operations of all time, particularly in this day and age, now that a lot of the immune suppression problems have been dealt with,” he said.

However, from a public health perspective cardiac transplantation is relatively ineffective, Dr. Lytle added. Although an estimated 250,000-300,000 Americans under age 75 have class IIIb/IV heart failure and are thus potential candidates for cardiac replacement therapy, the limited donor organ supply means only about 3,000 transplants can be done annually. Mechanical replacement using left ventricular assist devices as destination therapy will have a much greater impact in this population than will organ transplantation, he predicted.

Dr. Lytle reported no relevant financial interests.

Thirty-day mortality doubles in centers that perform fewer than 10 transplants a year.

Source DR. LYTLE

Recommended Reading

Drug-Eluting Stents for Primary PCI Superfluous?
MDedge Cardiology
Delaying Surgery After PCI Cuts Kidney Injury
MDedge Cardiology
Post-CABG Renal Injury Raises Mortality Risk
MDedge Cardiology
CABG Outcomes Found Worse With Off-Pump Procedures
MDedge Cardiology
NSAID 'Useless' for Postop Pericardial Effusions
MDedge Cardiology
Slow Gait Ups Surgery Risks
MDedge Cardiology
Hospital Infections Put STEMI Patients at Risk
MDedge Cardiology
Ticagrelor With Invasive Strategy Cut Deaths
MDedge Cardiology
PCI for Complex CAD Ups Revascularization Risk in Diabetes
MDedge Cardiology
Drugs Excel for Asymptomatic Carotid Stenosis
MDedge Cardiology